logo

Nicotine Delivery to the aerosol of a heat-Not-Burn Tobacco Product: Comparison With a Tobacco Cigarette and E-Cigarettes

Non-clinical
Chemical
Analysis

Farsalinos (2018)

Do flavouring compounds contribute to aldehyde emissions in e-cigarettes?

Non-clinical
Chemical
Analysis

Farsalinos (2018)

Changes from 2017 to 2018 in e-cigarette use and in ever marijuana use with e-cigarettes among US adolescents: analysis of the National Youth Tobacco Survey.

Population Clinical
Consumer Use
Factors Influencing Patterns Of Use

Farsalinos (2021)

The Association Between Risk Behaviors and Vaping Among Youth in New Mexico.

Population Clinical
Consumer Use
Youth Use & Appeal

Fatemi (2021)

adverse Experience Reports of Seizures in Youth and Young adult Electronic Nicotine Delivery Systems Users.

Individual Clinical
Safety
Adverse Effects

Faulcon (2020)

Guidance for Industry: Reporting harmful and Potentially harmful Constituents in Tobacco Products and Tobacco Smoke Under Section 904(a)(3) of the Federal Food, Drug, and Cosmetic act: DRaFT GUIDaNCE

Policy

FDa (2012)

DEPaRTMENT OF hEaLTh aND hUMaN SERVICES Food and Drug administration [Docket No. FDa–2012–N–0143] harmful and Potentially harmful Constituents in Tobacco Products and Tobacco Smoke; Established List

Policy

FDa (2012)

DEPaRTMENT OF hEaLTh aND hUMaN SERVICES: Food and Drug administration [Docket No. FDa–2012–D–0049] Draft Guidance for Industry: Reporting harmful and Potentially harmful Constituents in Tobacco Products and Tobacco Smoke Under the Federal Food, Drug, and Cosmetic act; availability

Policy

FDa (2012)

Guidance for Industry - S2(R1) Genotoxicity Testing and Data Interpretation for Pharmaceuticals Intended for human Use

Policy

FDa (2012)

Preliminary Scientific Evaluation of the Possible Public health Effects of Menthol Versus Nonmenthol Cigarettes

Population Clinical
Consumer Use
Flavor Appeal

FDa (2013)